SMS Pharmaceuticals Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

335.70 -2.55 (-0.75%)Updated : 14 Jan 2026

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	678.08	624.15	499.60	437.69
Other Net	-0.68	-0.22	-0.75	1.05
Diluted Weighted Average Shares	8.47	8.47	8.47	8.47
Gain( Loss)on Saleof Assets	0.02	0.04	-0.07	0.00
Depreciation/ Amortization	34.34	31.52	32.13	32.15
Operating Income	104.67	85.11	22.45	82.18
Net Income	69.14	49.83	-7.06	62.22
Income Availableto Com Excl Extra Ord	69.14	49.83	-7.06	62.22
Net Income Before Taxes	92.34	66.11	5.35	68.50
Minority Interest	0.00	-	-	-
Net Income After Taxes	67.40	49.20	3.88	67.88
Income Availableto Com Incl Extra Ord	69.14	49.83	-7.06	62.22
Costof Revenue Total	504.24	480.71	379.78	315.99
Gross Profit	278.51	228.56	142.27	203.88
Interest Inc( Exp) Net- Non- Op Total	-11.67	-18.82	-16.28	-14.73
Diluted Net Income	69.14	49.83	-7.06	62.22
DPS- Common Stock Primary Issue	0.40	0.40	0.30	0.30
Provisionfor Income Taxes	24.94	16.91	1.47	0.62
Equity In Affiliates	1.74	0.63	-10.94	-5.66
period Type	-	-	-	-
Net Income Before Extra Items	69.14	49.83	-7.06	62.22
Total Revenue	782.75	709.26	522.05	519.87
period Length	12.00	12.00	12.00	12.00
Revenue	782.75	709.26	522.05	519.87
Selling/ General/ Admin Expenses Total	139.50	111.93	87.69	89.55
Diluted Normalized EPS	8.16	5.88	-0.83	7.35
Diluted EPS Excluding Extra Ord Items	8.16	5.89	-0.83	7.35